P01308 (INS_HUMAN) Homo sapiens (Human)
Insulin UniProtKBInterProSTRINGInteractive Modelling
110 aa; Sequence (Fasta) ;
2 identical sequences: Homo sapiens: I3WAC9; Gorilla gorilla gorilla: Q6YK33
Models are currently being built for this target protein.
(Depending on server load, it will take approximately 15-30 minutes before the new models are available in SWISS-MODEL Repository)
Please note that SMR updates are performed with default parameters for template selection and quality filters. If you prefer to interactively explore various models build on different templates, please use SWISS-MODEL workspace.
Available Structures
368 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| 0.92A structure of 2Zn human insulin at 100K |
Heteromer | 100 | 3×ZN; | |||
| X-ray Structure of Human Recombinant 2Zn insulin at 0.92 Angstrom |
Heteromer | 100 | 6×ZN; 3×ACT; 3×POL; | |||
| Insulin with proline analog HzP at position B28 in the T2 state |
Heteromer | 100 | ||||
| T6 Human Insulin at 1.0 A Resolution |
Heteromer | 100 | 6×ZN; | |||
| High resolution structure of the manganese derivative of insulin |
Heteromer | 100 | 1×NA; 1×MN; | |||
| Crystal Structure Analysis of Cu Human Insulin Derivative |
Heteromer | 100 | ||||
| 1.15A structure of human 2Zn insulin at 293K |
Heteromer | 100 | 3×ZN; | |||
| Crystal structure of D-ProB26-DTriA analogue of human insulin |
Heteromer | 96.15 | ||||
| Insulin with proline analog Pip at position B28 in the T2 state |
Heteromer | 100 | 2×NA; | |||
| Insulin with proline analog FyP at position B28 in the T2 state |
Heteromer | 100 | ||||
| Insulin with proline analog DhP at position B28 in the T2 state |
Heteromer | 100 | 2×NA; | |||
| Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engine… |
Heteromer | 100 | 2×16E; 6×RCO; 2×NA; 3×IMD; 2×ZN; | |||
| 1.2 A structure of T3R3 human insulin at 100 K |
Heteromer | 100 | 15×ZN; 12×CL; | |||
| Cubic Insulin SAD phasing at 14.2 keV |
Heteromer | 100 | ||||
| Insulin with proline analog ThioP at position B28 in the T2 state |
Heteromer | 100 | ||||
| X-Ray structure of Insulin Analog GLULISINE |
Heteromer | 100 | 6×ZN; | |||
| Insulin glulisine |
Heteromer | 100 | 6×ZN; 6×FMT; | |||
| Insulin with proline analog HzP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| The structure of a mutant insulin uncouples receptor binding from protein allostery. An electrostat… |
Heteromer | 100 | 6×ZN; | |||
| Insulin with proline analog AzeP at position B28 in the T2 state |
Heteromer | 100 | 2×NA; | |||
| 1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT 100 K |
Heteromer | 100 | 15×ZN; 12×CL; | |||
| Insulin with proline analog FzP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; 6×NA; 1×GOL; 1×ACN; | |||
| Insulin with proline analog HyP at position B28 in the T2 state |
Heteromer | 100 | 2×NA; 2×GOL; | |||
| High resolution x-ray crystal structure of synthetic insulin lispro |
Heteromer | 100 | 3×IPH; 1×ZN; 1×CL; | |||
| Structure of the T6 human insulin derivative with nickel at 1.35 A resolution |
Heteromer | 100 | 1×NI; 1×NA; | |||
| Zinc free, dimeric human insulin determined to 1.35 Angstrom resolution |
Heteromer | 100 | 2×EDO; | |||
| Design of an insulin analog with enhanced receptor-binding selectivity. Rationale, structure, and t… |
Heteromer | 95.0 | 1×ZN; | |||
| Xray crystal structure of isotope-labeled human insulin |
Heteromer | 100 | ||||
| Structure of human insulin cocrystallized with ARG-12 peptide in presence of urea |
Heteromer | 100 | 2×NA; 6×RCO; 8×URE; 2×ZN; 2×CL; 4×ARF; | |||
| Monoclinic human insulin in complex with p-coumaric acid |
Heteromer | 100 | 2×ZN; 3×PO4; 5×HC4; 1×SCN; | |||
| Crystal structure of human insulin, crystallised in the presence of macrophage migration inhibitory… |
Heteromer | 100 | 1×SO4; 2×GOL; | |||
| INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE |
Heteromer | 100 | 1×ZN; | |||
| Crystal structure of desB30 insulin produced by cell free protein synthesis |
Heteromer | 100 | ||||
| Crystal structure of insulin detemir |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; 6×MYR; | |||
| Crystal structure of dodecamer human insulin with double C-axis length of the hexamer 2 Zn insulin … |
Heteromer | 100 | 6×ZN; | |||
| Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form II |
Heteromer | 100 | 1×SO4; 1×ACT; | |||
| Crystal structure of human insulin mutant B20 D-ala, B23 D-ala |
Heteromer | 100 | ||||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Insulin co-crystallizes in the presence of it beta-cell chaperone sulfatide |
Heteromer | 100 | 6×ZN; 6×CL; 3×NA; | |||
| Semi-synthetic analogue of human insulin NMeTyrB26-insulin in hexamer form |
Heteromer | 100 | 6×IPH; 2×CL; 2×ZN; 1×GOL; | |||
| STRUCTURE OF INSULIN |
Heteromer | 100 | 1×CRS; 1×ZN; 1×CL; | |||
| Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)ami… |
Heteromer | 95.24 | 3×IMD; 3×KUT; | |||
| Human insulin analogue (D-ProB8)-insulin |
Heteromer | 100 | 2×CL; | |||
| insuline(60sec) and UV laser excited fluorescence |
Heteromer | 100 | ||||
| Crystal structure of an cyclohexylalanine substituted insulin analog. |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| High resolution x-ray crystal structure of isotope-labeled ester-insulin |
Heteromer | 100 | ||||
| Structure of human insulin cocrystallized with protamine and urea |
Heteromer | 100 | 2×NA; 6×CRS; 12×URE; 2×ZN; 2×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human insulin with intra-chain chemical crosslink between modified B27 and B30 |
Heteromer | 100 | 10×IPH; 2×ZN; 2×CL; | |||
| A6-A11 trans-dicarba human insulin |
Heteromer | 90.48 | ||||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Recombinant Human Insulin |
Heteromer | 100 | ||||
| Human insulin B26Phe mutant crystal structure |
Heteromer | 100 | 1×SO4; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| STRUCTURE OF B28 ASP INSULIN IN COMPLEX WITH PHENOL |
Heteromer | 100 | 2×IPH; 1×ZN; 1×CL; | |||
| Structure of human insulin |
Heteromer | 100 | 1×ZN; 1×CL; | |||
| Human insulin |
Heteromer | 100 | ||||
| CRYSTALLOGRAPHIC EVIDENCE FOR DUAL COORDINATION AROUND ZINC IN THE T3R3 HUMAN INSULIN HEXAMER |
Heteromer | 100 | 1×ZN; 1×CL; | |||
| High resolution crystal structure of racemic ester insulin |
Heteromer | 100 | 2×PEG; 1×GOL; | |||
| Structure of LysB29(Nepsilon omega-carboxyheptadecanoyl) des(B30) Human Insulin |
Heteromer | 100 | 6×RCO; 6×ZN; 6×CL; | |||
| Crystallographic and solution studies of N-lithocholyl insulin: a new generation of prolonged-actin… |
Heteromer | 100 | 6×CRS; 6×UZ9; 6×ZN; 6×CL; | |||
| Four-Disulfide Insulin Analog A22/B22 |
Heteromer | 100 | 7×IPH; 2×ACN; 2×ZN; 2×CL; 2×GOL; | |||
| Insulin Lispro Analog |
Heteromer | 100 | 7×CRS; 2×ZN; 2×GOL; 2×CL; | |||
| Insulin at pH 2: structural analysis of the conditions promoting insulin fibre formation. |
Heteromer | 100 | 1×SO4; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Insulin single mutant INS-Q |
Heteromer | 100 | 2×SO4; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Crystal structure of human insulin analogue (NMe-AlaB8)-insulin crystal form I |
Heteromer | 100 | ||||
| Human insulin with intra-chain chemical crosslink between modified B24 and B29 |
Heteromer | 100 | 1×SO4; | |||
| Structure of human insulin in presence of urea at pH 7.0 |
Heteromer | 100 | 8×RCO; 7×URE; 2×ZN; 5×CL; 1×GOL; | |||
| Crystal Structure of human zinc insulin at pH 5.5 |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Structure of human insulin |
Heteromer | 100 | 1×ZN; 1×CL; | |||
| Crystal structure of insulin |
Heteromer | 100 | 3×IPH; 2×ZN; 2×CL; 2×MYR; | |||
| Structure of human insulin in presence of thiocyanate at pH 7.0 |
Heteromer | 100 | 6×RCO; 2×ZN; 2×SCN; 1×GOL; | |||
| Crystalization of human zinc insulin at pH 5.5 |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Serial Macromolecular Crystallography at ALBA Synchrotron Light Source - Insulin |
Heteromer | 100 | 1×ZN; 1×CL; | |||
| Crystal Structure of the cobalt human insulin derivative |
Heteromer | 100 | 1×CO; | |||
| Structural and biophysical characterization of a covalent insulin dimer formed during storage of ne… |
Heteromer | 100 | ||||
| Crystal structure of aspart insulin at pH 6.5 |
Heteromer | 100 | 6×CRS; 6×ZN; 6×CL; | |||
| Structure of the rhombohedral form of the M-cresol/insulin R6 hexamer |
Heteromer | 100 | 9×CRS; 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Crystal structure of human zinc insulin at pH 6.5 |
Heteromer | 100 | 6×ZN; 6×CL; 3×MG; | |||
| Enhancing the activity of insulin at receptor edge: crystal structure and photo-cross-linking of A8… |
Heteromer | 95.24 | 3×ZN; 3×CL; | |||
| Crystal structure of human insulin, crystallised in the presence of macrophage migration inhibitory… |
Heteromer | 100 | 1×SO4; | |||
| Structure of gadolinium-caged cobalt (III) insulin hexamer |
Heteromer | 100 | 6×CO; 3×GD; 3×CL; | |||
| Crystal structure form ultalente insulin microcrystals |
Heteromer | 100 | 6×ZN; 12×CL; | |||
| Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engine… |
Heteromer | 100 | 3×ZN; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| STRUCTURE OF INSULIN |
Heteromer | 100 | 1×IPH; 1×ZN; 1×CL; 1×MYR; | |||
| Human insulin B26Asn mutant crystal structure |
Heteromer | 100 | ||||
| Human insulin analog: [GluB10,HisA8,ArgA9]-DOI |
Heteromer | 90.48 | ||||
| Human insulin |
Heteromer | 100 | ||||
| Crystal structure of human insulin with Ni+2 complex |
Heteromer | 100 | 6×NI; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Crystal structure of aspart insulin at pH 6.5 |
Heteromer | 100 | 6×CRS; 6×ZN; 6×CL; | |||
| Human insulin in complex with serotonin and arginine |
Heteromer | 100 | 6×ZN; 6×CL; 3×ARG; 3×SRO; | |||
| Structure of the monoclinic form of the M-cresol/insulin R6 hexamer |
Heteromer | 100 | 7×CRS; 2×ZN; 2×CL; 1×NA; | |||
| Enhancing the Therapeutic Properties of a Protein by a Designed Zinc-Binding Site, Structural princ… |
Heteromer | 90.48 | 9×ZN; 6×CL; 3×IPH; | |||
| Crystal structure of humnan insulin Sr+2 complex |
Heteromer | 100 | 6×SR; | |||
| THE STRUCTURE OF A COMPLEX OF HEXAMERIC INSULIN AND 4'-HYDROXYACETANILIDE |
Heteromer | 100 | 1×ZN; | |||
| THE STRUCTURE OF A COMPLEX OF HEXAMERIC INSULIN AND 4'-HYDROXYACETANILIDE |
Heteromer | 100 | 1×ZN; | |||
| Human insulin with intra-chain chemical crosslink between modified B27 and B29 |
Heteromer | 100 | ||||
| NMePheB25 insulin analogue crystal structure |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| The structure of the resorcinol/insulin R6 hexamer |
Heteromer | 100 | 8×RCO; 2×ZN; 2×CL; 1×NA; | |||
| CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) INSULIN |
Heteromer | 100 | 1×ZN; | |||
| Crystal structure of human zinc insulin at pH 6.5 |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| insuline(1sec) and UV laser excited fluorescence |
Heteromer | 100 | ||||
| Dehydrated T6 human insulin at 100 K |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| TyrB25,NMePheB26,LysB28,ProB29-insulin analogue crystal structure |
Heteromer | 100 | 6×IPH; 2×CL; 2×ZN; | |||
| Structure of human insulin in presence of thiocyanate at pH 6.5 |
Heteromer | 100 | 6×RCO; 2×ZN; 2×SCN; | |||
| A novel covalently linked insulin dimer |
Heteromer | 100 | ||||
| Crystal structure of ni human ARG-insulin |
Heteromer | 100 | 12×NI; 3×NA; 3×CL; | |||
| INSULIN, MONOCLINIC CRYSTAL FORM |
Heteromer | 100 | 7×IPH; 2×ZN; 2×CL; | |||
| Insulin Icodec - A14E B16H B25H B29Ne-C20 diacid-LgGlu-2xAdo desB30 human insulin |
Heteromer | 95.24 | 2×ACT; | |||
| Structure of Human Arg-Insulin |
Heteromer | 100 | 6×ZN; | |||
| CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN INACTIVE CHIRAL ANALOGUE: IMPLICATIONS FOR THE MECHANIS… |
Heteromer | 100 | 3×ZN; | |||
| Insulin fibrillation is the Janus face of induced fit. A chiaral clamp stabilizes the native state … |
Heteromer | 100 | 3×ZN; 3×CL; | |||
| HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH RESORCINOL |
Heteromer | 100 | 6×RCO; 2×ZN; 2×CL; | |||
| Crystal structure of an unstable insulin analog with native activity. |
Heteromer | 95.24 | 6×ZN; | |||
| Structure DeltaA1-A4 insulin |
Heteromer | 100 | 6×RCO; 2×ZN; 2×CL; | |||
| Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of pro… |
Heteromer | 85.71 | 6×ZN; 6×CL; 3×IPH; | |||
| Crystal Structure Analysis of the Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; 3×GOL; | |||
| Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engine… |
Heteromer | 100 | 3×IPH; 3×16E; 3×ZN; 3×CL; | |||
| Human insulin in complex with cucurbit[7]uril |
Heteromer | 100 | ||||
| T3R3 form of Human insulin with single Zn |
Heteromer | 100 | 6×CRS; 3×NA; 3×ZN; 3×CL; | |||
| Structure of human insulin in presence of urea at pH 6.5 |
Heteromer | 100 | 6×RCO; 6×URE; 2×ZN; 2×CL; | |||
| Insulin with proline analog PiP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; | |||
| Structural properties of the B25Tyr-NMe-B26Phe insulin mutant. |
Heteromer | 100 | 6×IPH; 2×ZN; | |||
| Crystal structure of RB human arg-insulin |
Heteromer | 100 | 3×NA; 3×RB; | |||
| Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 7.5 |
Heteromer | 100 | ||||
| Crystal Structure of Human Insulin complexed with Cu+2 metal ion |
Heteromer | 100 | 6×CU; | |||
| Forestalling insulin fibrillation by insertion of a chiral clamp mechanism-based application of pro… |
Heteromer | 100 | 6×ZN; 3×IPH; 3×CL; | |||
| Human insulin in complex with serotonin |
Heteromer | 100 | 6×ZN; 6×CL; 3×SRO; | |||
| Monoclinic crystalline form of human insulin, complexed with meta-cresol |
Heteromer | 100 | 6×CRS; 6×EDO; 2×ZN; 2×IS8; | |||
| Insulin with proline analog HyP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Structure of human insulin cocrystallized with protamine |
Heteromer | 100 | 6×RCO; 2×ZN; 2×CL; | |||
| Crystal structure of MN human arg-insulin |
Heteromer | 100 | 6×MN; 6×CL; | |||
| Dehydrated T6 human insulin at 295 K |
Heteromer | 100 | 2×ZN; | |||
| Insulin analog containing a YB26W mutation |
Heteromer | 100 | 6×ZN; 3×IPH; 3×CL; | |||
| Insulin with proline analog DfP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| Ligand controlled assembly of hexamers, dihexamers, and linear multihexamer structures by an engine… |
Heteromer | 100 | ||||
| LYS(B28)PRO(B29)-HUMAN INSULIN |
Heteromer | 100 | 1×ZN; | |||
| Human insulin in complex with the analytical antibody S1 Fab |
Heteromer | 100 | 2×NAG; | |||
| Crystal Structure of an iodinated insulin analog |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal… |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| Human Insulin |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR COMPLEXED WITH PHENOL |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| Insulin fibrillation is the Janus face of induced fit. A chiral clamp stabilizes the native state a… |
Heteromer | 100 | 3×IPH; 3×ZN; 3×CL; | |||
| Diabetes-Associated Mutations in Human Insulin: Crystal Structure and Photo-Cross-Linking Studies o… |
Heteromer | 95.24 | 3×IPH; 3×ZN; 3×CL; | |||
| Temperature induces a shift from the dihexamer to the hexamer form of insulin |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; 6×MYR; | |||
| Crystal structure of aspart insulin at pH 8.5 |
Heteromer | 100 | 6×CRS; 6×ZN; 6×CL; | |||
| HUMAN INSULIN HEXAMERS WITH CHAIN B HIS MUTATED TO TYR |
Heteromer | 100 | 6×ZN; 3×CL; | |||
| Insulin with proline analog DhP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; | |||
| Insulin's biosynthesis and activity have opposing structural requirements: a new factor in neonatal… |
Heteromer | 100 | 6×ZN; 6×CL; 3×IPH; | |||
| HUMAN INSULIN MUTANT SERB9GLU |
Heteromer | 100 | ||||
| Crystal structure of aspart insulin at pH 8.5 |
Heteromer | 100 | 6×CRS; 6×ZN; 6×CL; | |||
| Non-standard Design of Unstable Insulin Analogues with Enhanced Activity |
Heteromer | 95.24 | 3×ZN; | |||
| Crystal structure of LysB22-AspB28 insulin analog at ambient structure |
Heteromer | 100 | 6×ZN; 6×CL; | |||
| Crystal structure of aspart insulin at pH 6.5 |
Heteromer | 100 | 6×CRS; 6×ZN; 6×CL; | |||
| Semi-synthetic analogue of human insulin ProB26-DTI |
Heteromer | 100 | 6×IPH; 2×ZN; 2×CL; | |||
| Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SC… |
Heteromer P06213; | 100.0 | 2×NAG; 1×NAG; 1×NAG; 1×SO4; 1×GOL; 1×NAG; | |||
| di-hexamer form of insulin detemir at ambient temperature |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; 6×MYR; | |||
| crystal structure of human insulin degrading enzyme in complex with iodinated insulin |
Heteromer P14735; | 100 | 1×ZN; 4×DIO; | |||
| Temperature induces a shift from the dihexamer to the hexamer form of insulin (200K) |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; 6×MYR; | |||
| hexamer form of insulin detemir at ambient temperature |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; 6×MYR; | |||
| Temperature induces a shift from the dihexamer to the hexamer form of insulin (300K) |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; 6×MYR; | |||
| Human insulin in complex with the human insulin microreceptor in turn in complex with Fv 83-7 |
Heteromer P06213; | 100 | 1×NAG; 2×NAG; 2×NAG; | |||
| Human insulin in complex with the analytical antibody S1 Fab and the analytical antibody HUI-001 Fab |
Heteromer | 100 | ||||
| Biosynthetic engineered B28K-B29P human insulin monomer structure in in water/acetonitrile solution… |
Heteromer | 100 | ||||
| Biosynthetic engineered A22S-B3K-B31R human insulin monomer structure in water/acetonitrile solutio… |
Heteromer | 100 | ||||
| tentative model of the human insulin receptor ectodomain bound by three insulin |
Heteromer P06213; | 100 | ||||
| Solution structure of [GlnB22]-insulin mutant at pH 1.9 |
Heteromer | 100 | ||||
| Biosynthetic engineered B28K-B29P human insulin monomer structure in in water solutions. |
Heteromer | 100 | ||||
| INSULIN MUTANT B16 GLU, B24 GLY, DES-B30, NMR, 20 STRUCTURES |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALLO-ILE, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 ST… |
Heteromer | 100 | ||||
| human insulin receptor ectodomain bound by 4 insulin |
Heteromer P06213; | 100 | ||||
| INSULIN MUTANT A3 GLY,(B1, B10, B16, B27)GLU, DES-B30, NMR, 19 STRUCTURES |
Heteromer | 95.24 | ||||
| Solution structure of the [AibB8,LysB28,ProB29]-insulin analogue |
Heteromer | 100 | ||||
| INSULIN MUTANT A8 HIS,(B1, B10, B16, B27)GLU, DES-B30, NMR, 26 STRUCTURES |
Heteromer | 95.24 | ||||
| THREE-DIMENSIONAL SOLUTION STRUCTURE OF AN INSULIN DIMER. A STUDY OF THE B9(ASP) MUTANT OF HUMAN IN… |
Heteromer | 100 | ||||
| NMR structure of B25-(alpha, beta)-dehydro-phenylalanine insulin |
Heteromer | 100 | ||||
| Solution structure of B24G insulin |
Heteromer | 100 | ||||
| SOLUTION STRUCTURE OF THE SUPERACTIVE MONOMERIC DES-[PHE(B25)] HUMAN INSULIN MUTANT. ELUCIDATION OF… |
Heteromer | 100 | ||||
| Dynamics of insulin probed by 1H-NMR amide proton exchange anomalous flexibility of the receptor-bi… |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCT… |
Heteromer | 100 | ||||
| Human Insulin Mutant A22Gly-B31Lys-B32Arg |
Heteromer | 100 | ||||
| HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 STRUCTURES |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTU… |
Heteromer | 95.24 | ||||
| Structure of [L-HisB24] insulin analogue at pH 1.9 |
Heteromer | 100 | ||||
| ThrA3-DKP-insulin |
Heteromer | 95.24 | ||||
| Structure of [L-HisB24] insulin analogue at pH 8.0 |
Heteromer | 100 | ||||
| NMR structure of human insulin mutant His-B10-Asp, Pro-B28-Lys, Lys-B29-Pro, 20 structures |
Heteromer | 100 | ||||
| Structure of [D-HisB24] insulin analogue at pH 1.9 |
Heteromer | 100 | ||||
| Solution structure of the monomeric [Thr(B27)->Pro,Pro(B28)->Thr] insulin mutant (PT insulin) |
Heteromer | 100 | ||||
| NMR structure of human insulin mutant GLY-B8-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structur… |
Heteromer | 100 | ||||
| Structure of [D-HisB24] insulin analogue at pH 8.0 |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-THR, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCT… |
Heteromer | 100 | ||||
| Cryo-EM structure of the IGF1R/insulin complex |
Heteromer P08069; | 100 | 4×NAG; | |||
| NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS-B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCT… |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO… |
Heteromer | 90.48 | ||||
| PARADOXICAL STRUCTURE AND FUNCTION IN A MUTANT HUMAN INSULIN ASSOCIATED WITH DIABETES MELLITUS |
Heteromer | 100 | ||||
| NMR structure of human insulin mutant gly-b8-d-ala, his-b10-asp, pro-b28-lys, lys-b29-pro, 20 struc… |
Heteromer | 100 | ||||
| Biosynthetic engineered A21K-B31K-B32R human insulin monomer structure in water/acetonitrile soluti… |
Heteromer | 95.24 | ||||
| Enhancing the activity of insulin by stereospecific unfolding |
Heteromer | 100 | ||||
| NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16) |
Heteromer | 100 | ||||
| Structure and dynamics of des-pentapeptide-insulin in solution: the molten-globule hypothesis. |
Heteromer | 100 | ||||
| Receptor binding redefined by a structural switch in a mutant Human Insulin |
Heteromer | 100 | ||||
| HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 STRUCTURES |
Heteromer | 90.48 | ||||
| MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP, NMR, 20 STRU… |
Heteromer | 100 | ||||
| Structure of full-length human insulin fibrils |
Heteromer | 100 | ||||
| NMR structure of human insulin mutant glu-b21-d-glu, his-b10 asp pro-b28-lys, lys-b29-pro, 20 struc… |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN IN 20% ACETIC ACID, ZINC-FREE, 10 STRUCTURES |
Heteromer | 100 | ||||
| allo-ThrA3 DKP-insulin |
Heteromer | 95.24 | ||||
| Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 1.9 |
Heteromer | 100 | ||||
| AbaA3-DKP-insulin |
Heteromer | 95.24 | ||||
| Solution structure of [B26-B29 triazole cross-linked]-insulin analogue at pH 8.0 |
Heteromer | 100 | ||||
| Solution structure of [GlyB24,B27-B29 triazole cross-linked]-insulin analogue at pH 1.9 |
Heteromer | 100 | ||||
| B24Y DKP insulin |
Heteromer | 100 | ||||
| NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Str… |
Heteromer | 100 | ||||
| R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 10 STRUCTURES |
Heteromer | 100 | 2×ZN; 6×IPH; | |||
| R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 20 STRUCTURES |
Heteromer | 100 | 6×IPH; | |||
| R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REFINED AVERAGE STRUCTURE |
Heteromer | 100 | 6×IPH; | |||
| R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'GREEN' SUBSTATE, AVERAGE STRUCTURE |
Heteromer | 100 | 6×IPH; | |||
| R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, 'RED' SUBSTATE, AVERAGE STRUCTURE |
Heteromer | 100 | 6×IPH; | |||
| NMR Structure of human insulin mutant GLY-B20-D-ALA, GLY-B23-D-ALA PRO-B28-LYS, LYS-B29-PRO, 20 Str… |
Heteromer | 85.71 | ||||
| Humal Insulin Mutant B31Lys-B32Arg |
Heteromer | 100 | ||||
| Crystal structure of insulin hexamer fitted into cryo EM density map where each dimer was kept as r… |
Heteromer | 100 | ||||
| Insulin receptor ectodomain dimer complexed with two IRPA-9 partial agonists |
Heteromer P06213; | 100 | 4×NAG; 2×NAG; 2×NAG; 2×NAG; 4×NAG; | |||
| NMR structure of human insulin mutant GLY-B8-D-SER, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 struct… |
Heteromer | 100 | ||||
| Enhancing the activity of insulin by stereospecific unfolding |
Heteromer | 100 | ||||
| NMR STRUCTURE OF HUMAN INSULIN under Amyloidogenic Condition, 15 STRUCTURES |
Heteromer | 100 | ||||
| NMR structure of human insulin monomer in 35% CD3CN zinc free, 50 structures |
Heteromer | 100 | ||||
| NMR structure of human insulin mutant HIS-B5-ALA, HIS-B10-ASP PRO-B28-LYS, LYS-B29-PRO, 20 structur… |
Heteromer | 100 | ||||
| FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA |
Heteromer | 100 | 4×ZN; 4×CL; 2×NA; | |||
| R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), NMR, 10 STRUCTURES |
Heteromer | 100 | 2×ZN; 6×IPH; | |||
| Modified A22Gly-B31Arg Human Insulin |
Heteromer | 100 | ||||
| FIRST PROTEIN STRUCTURE DETERMINED FROM X-RAY POWDER DIFFRACTION DATA |
Heteromer | 100 | 2×ZN; 2×CL; 1×NA; | |||
| Solution structure of human insulin at pH 1.9 |
Heteromer | 100 | ||||
| The T2 structure of polycrystalline cubic human insulin |
Heteromer | 100 | ||||
| Human insulin analog: [GluB10,TyrB20]-DOI |
Heteromer | 100 | ||||
| Cubic insulin crystal, Esrapid, at pH 2 |
Heteromer | 100 | 1×SO4; | |||
| Cubic insulin crystal, Esrapid, at pH 3 |
Heteromer | 100 | 1×SO4; | |||
| Cubic insulin crystal, Esrapid, at pH 5 |
Heteromer | 100 | 1×SO4; | |||
| Human insulin analog: [GluB10,HisA8,ArgA9,TyrB20]-DOI |
Heteromer | 90.0 | ||||
| Semi-synthetic analogue of human insulin NMeAlaB26-insulin at pH 3.0 |
Heteromer | 100 | 1×NA; | |||
| Cubic insulin crystal, Esrapid, at pH 4 |
Heteromer | 100 | 1×SO4; | |||
| Semi-synthetic highly active analogue of human insulin NMeAlaB26-DTI- NH2 |
Heteromer | 100 | 4×ACT; | |||
| Semi-synthetic analogue of human insulin NMeTyrB26-insulin in monomer form |
Heteromer | 100 | 2×ACT; | |||
| Insulin glargine crystal structure 1 |
Heteromer | 100 | ||||
| X-Ray structure of Insulin Glargine |
Heteromer | 100 | ||||
| Crystal structure of the B24His-insulin - human analogue |
Heteromer | 100 | 1×SO4; | |||
| Cubic insulin crystal, Esrapid, at pH 6 |
Heteromer | 100 | 1×SO4; | |||
| Human insulin trans-HypB26-DTIA analogue |
Heteromer | 96.0 | 1×SO4; | |||
| Insulin glargine crystal structure 2 |
Heteromer | 100 | ||||
| Despentapeptide insulin in acetic acid (pH 2) |
Heteromer | 100 | 3×SO4; | |||
| Crystal structure of human insulin trans-HypB26-DTI analogue |
Heteromer | 100 | 2×SO4; 1×IPH; | |||
| Semi-synthetic analogue of human insulin ProB26-DTI in monomer form |
Heteromer | 100 | ||||
| Crystal structure of lisargine |
Heteromer | 100 | 2×ZN; 2×CL; | |||
| Insulin with proline analog ThioP at position B28 in the R6 state |
Heteromer | 100 | 6×IPH; 6×ZN; 6×CL; | |||
| Human insulin in complex with serotonin and arginine |
Heteromer | 100.0 | 6×ZN; 6×CL; 3×ARG; 3×SRO; | |||
| Semi-synthetic highly active analogue of human insulin NMeHisB26-DTI- NH2 |
Heteromer | 100 | 2×ACT; | |||
| Semi-synthetic highly active analogue of human insulin D-ProB26-DTI- NH2 |
Heteromer | 100 | ||||
| Crystal structure of human insulin-degrading enzyme in complex with insulin |
Heteromer P14735; | 100 | 1×ZN; | |||
| Human insulin B26Gly mutant crystal structure |
Heteromer | 100 | 1×SO4; | |||
| Insulin triple mutant INS-RQD |
Heteromer | 100 | ||||
| Full-length insulin receptor bound with site 2 binding deficient mutant insulin (B-L17R) -- symmetr… |
Heteromer P15208; | 96.3 | ||||
| Full-length insulin receptor bound with unsaturated insulin WT (2 insulin bound) symmetric conforma… |
Heteromer P15208; | 100.0 | ||||
| INSULIN MUTANT (B1, B10, B16, B27)GLU, DES-B30, NMR, 25 STRUCTURES |
Heteromer | 100 | ||||
| Full-length insulin receptor bound with unsaturated insulin WT (1 insulin bound) asymmetric conform… |
Heteromer P15208; | 100.0 | ||||
| Full-length insulin receptor bound with unsaturated insulin WT (2 insulins bound) asymmetric confor… |
Heteromer P15208; | 100.0 | ||||
| Full-length insulin receptor bound with unsaturated insulin WT (2 insulins bound) asymmetric confor… |
Heteromer P15208; | 100.0 | ||||
| Cryo-EM structure of 4 insulins bound full-length mouse IR mutant with physically decoupled alpha C… |
Heteromer P15208; | 100.0 | ||||
| Cryo-EM structure of 4 insulins bound full-length mouse IR mutant with physically decoupled alpha C… |
Heteromer P15208; | 100.0 | ||||
| Cryo-EM structure of 4 insulins bound full-length mouse IR mutant with physically decoupled alpha C… |
Heteromer P15208; | 100.0 | ||||
| Full-length insulin receptor bound with both site 1 binding deficient mutant insulin (A-V3E) and si… |
Heteromer P15208; | 100 | ||||
| Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 1 In… |
Heteromer P06213; | 100.0 | ||||
| Full-length insulin receptor bound with site 2 binding deficient mutant insulin (A-L13R) -- symmetr… |
Heteromer P15208; | 100 | ||||
| Full-length insulin receptor bound with site 2 binding deficient mutant insulin (B-L17R) -- asymmet… |
Heteromer P15208; | 96.3 | ||||
| Full-length insulin receptor bound with site 2 binding deficient mutant insulin (A-L13R) -- asymmet… |
Heteromer P15208; | 100 | ||||
| Cryo-EM Structure for the Insulin Binding Region in the Ectodomain of the Full-length Human Insulin… |
Heteromer P06213; | 100.0 | ||||
| Structure of Glargine insulin in 20% acetic acid-d4 (pH 1.9) |
Heteromer | 100 | ||||
| Cryo-EM Structure for the Ectodomain of the Full-length Human Insulin Receptor in Complex with 2 In… |
Heteromer P06213; | 100.0 | ||||
| Crystal structure of zinc free A14E, B25H, B29K(N(eps)-[2-(2-[2-(2-[2-(Octadecandioyl-gamma-Glu)ami… |
Heteromer | 95.24 | 4×NO3; | |||
| The crystal structure of a human seleno-insulin analog |
Heteromer | 90.48 | ||||
| Human insulin in complex with the analytical antibody OXI-005 Fab |
Heteromer | 100 | ||||
| Crystal structure form ultalente insulin microcrystals |
Heteromer | 100 | 12×ZN; 3×MPB; | |||
| Head region of insulin receptor ectodomain (A-isoform) bound to the non-insulin agonist IM462 |
Heteromer P06213; | 100 | 1×NAG; 6×NAG; | |||
| The insulin receptor ectodomain in complex with a venom hybrid insulin analog - "head" region |
Heteromer P06213; | 95.24 | 2×NAG; 12×NAG; | |||
| Cryo-EM structure of human insulin degrading enzyme in complex with insulin |
Heteromer P14735; | 100.0 | ||||
| The insulin receptor ectodomain in complex with four venom hybrid insulins - symmetric conformation |
Heteromer P06213; | 95.24 | 20×NAG; | |||
| The insulin receptor ectodomain in complex with three venom hybrid insulin molecules - asymmetric c… |
Heteromer P06213; | 95.24 | ||||
| Low resolution Cryo-EM structure of full-length insulin receptor bound to 3 insulin with visible dd… |
Heteromer P06213; | 100 | ||||
| Low resolution Cryo-EM structure of full-length insulin receptor bound to 3 insulin, conf 1 |
Heteromer P06213; | 100 | ||||
| Insulin receptor ectodomain dimer complexed with two IRPA-3 partial agonists |
Heteromer P06213; | 100 | ||||
| Leucine-zippered human insulin receptor ectodomain with single bound insulin - "upper" membrane-dis… |
Heteromer P06213; | 100 | 1×NAG; 9×NAG; | |||
| Low resolution Cryo-EM structure of the full-length insulin receptor bound to 2 insulin, conf 3 |
Heteromer P06213; | 100 | ||||
| Low resolution Cryo-EM structure of the full-length insulin receptor bound to 3 insulin, conf 2 |
Heteromer P06213; | 100 | ||||
| Cryo-EM structure of the complex IR with two insulin |
Heteromer P06213; | 100.0 | ||||
| Cryo-EM structure of the full-length human IGF-1R in complex with insulin |
Heteromer P08069; | 100 | 4×NAG; 1×NAG; 6×NAG; | |||
| Insulin Degrading Enzyme pO/pC |
Heteromer P14735; | 100 | ||||
| Insulin Degrading Enzyme pC/pC |
Heteromer P14735; | 100 | ||||
| Full-length insulin receptor bound with site 1 binding deficient mutant insulin (A-V3E) |
Heteromer P15208; | 100 | ||||
| Human insulin in complex with the analytical antibody HUI-018 Fab |
Heteromer | 100 | ||||
| Insulin Degrading Enzyme O/pC |
Heteromer P14735; | 100.0 | ||||
| Cryo-EM structure of insulin amyloid-like fibril that is composed of two antiparallel protofilaments |
Heteromer | 100 | ||||
| Insulin in complex with Site 1 of the human insulin receptor |
Heteromer P06213; | 100 | 1×NAG; 1×NAG; 3×NAG; | |||
| Insulin receptor ectodomain construct comprising domains L1-CR in complex with human insulin, Alpha… |
Heteromer P06213; | 100 | 1×NAG; 1×NAG; 3×NAG; | |||
| Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insuli… |
Heteromer P06213; | 100 | 1×NAG; 1×NAG; 2×NAG; | |||
| Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insuli… |
Heteromer P06213; | 100 | 1×NAG; 1×NAG; 2×NAG; | |||
| Cryo-EM structure of human insulin degrading enzyme in complex with insulin |
Heteromer P14735; | 100.0 | ||||
| crystal structure of human insulin-degrading enzyme in complex with insulin B chain |
Heteromer P14735; | 100.0 | 1×DIO; | |||
| human insulin receptor bound with two insulin molecules |
Heteromer F8WCM5; P06213; | 100 | ||||
| Cryo-EM structure of human insulin degrading enzyme in complex with FAB H11-E heavy chain, FAB H11-… |
Heteromer P0DOX5; P14735; Q6GMX0; | 100 | ||||
| human insulin receptor bound with A62 DNA aptamer and insulin |
Heteromer F8WCM5; P06213; | 100 | ||||
| Insulin Receptor ectodomain in complex with one insulin molecule |
Heteromer P01318; P06213; | 100 | ||||
| human insulin receptor bound with A43 DNA aptamer and insulin |
Heteromer F8WCM5; P06213; | 100 | ||||
| human insulin receptor bound with A62 DNA aptamer and insulin - locally refined |
Heteromer F8WCM5; P06213; | 100 | ||||
| Insulin Receptor ectodomain in complex with two insulin molecules |
Heteromer P01318; P06213; | 100 | 4×NAG; 2×NAG; 2×NAG; 2×NAG; 4×NAG; | |||
| Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry |
Heteromer P01318; P06213; | 100 | 4×NAG; 2×NAG; 2×NAG; 2×NAG; 4×NAG; | |||
| Crystal structure of Zn-bound human insulin-degrading enzyme in complex with insulin B chain |
Heteromer P14735; | 100.0 | 1×ZN; 1×DIO; | |||
| Crystal Structure Analysis of Fab1-Bound Human Insulin Degrading Enzyme (IDE) in Complex with Insul… |
Heteromer P14735; | 100 | 2×ZN; | |||
| Crystal Structure Analysis of Elbow-Engineered-Fab-Bound Human Insulin Degrading Enzyme (IDE) in Co… |
Heteromer P14735; | 100.0 | 2×EPE; 2×ZN; | |||
| Human TCR A2.13 in complex with DQ8-InsCpep |
Heteromer O19707; Q30069; | 86.67 | 1×NAG; 2×NAG; 1×PO4; 5×GOL; | |||
| Crystal structure of Proinsulin C-peptide bound to HLA-DQ8 |
Heteromer O19707; Q30069; | 86.67 | 1×NAG; 1×GOL; | |||
| immune complex |
Heteromer P01903; P01911; | 100 | 1×NAG; | |||
| Crystal structure of a human insulin peptide-HLA-DQ8 complex |
Heteromer P01909; P01920; | 100 | 1×NAG; | |||
| immune complex |
Heteromer P01903; P01911; | 100 | 1×NAG; 1×NAG; 3×MLI; | |||
| Human HLA-A*0201-ALWGPDPAAA |
Heteromer P04439; P61769; | 100 | ||||
| HLA-A02 carrying AQWGPDPAAA |
Heteromer P04439; P61769; | 90.0 | ||||
| Weak TCR binding to an unstable insulin epitope drives type 1 diabetes |
Heteromer P01902; P61769; | 100 | 3×EDO; 2×GOL; 4×SO4; | |||
| 1E6-A*0201-ALWGPDPAAA Complex, Triclinic |
Heteromer P04439; P61769; | 100 | ||||
| 1E6-A*0201-ALWGPDPAAA Complex, Monoclinic |
Heteromer P04439; P61769; | 100 | 2×SO4; | |||
| 1E6 TCR in Complex with HLA-A02 carrying AQWGPDPAAA |
Heteromer A0A0B4J271; A0A0B4J2E0; A0A5B9; P01848; P04439; P61769; | 90.0 | ||||
| Weak TCR binding to an unstable insulin epitope drives type 1 diabetes |
Heteromer P01902; P61769; | 88.89 | 4×GOL; 1×15P; 7×EDO; 2×SO4; | |||
| Weak TCR binding to an unstable insulin epitope drives type 1 diabetes |
Heteromer P01902; P61769; | 88.89 | 5×EDO; 2×GOL; 4×SO4; | |||
| Weak TCR binding to an unstable insulin epitope drives type 1 diabetes |
Heteromer P01902; P61769; | 100 | 1×EDO; 3×SO4; | |||
| Human MHC Class I, A24 Allele presenting LWM, Complex with 4C6 TCR |
Heteromer A0A5H2UYS3; P61769; | 100 | 3×SO4; 1×EPE; 3×EDO; | |||
| VEALYL peptide derived from human insulin chain B, residues 12-17 | homo-8-mer | 100 | ||||
| Crystal structure of human insulin desB30 precursor with an Alanine-Methionine-Lysine C-peptide in … | homo-6-mer | 100 | 12×ZN; 3×CL; 3×RCO; | |||
| Des-B29,B30-insulin | homo-6-mer | 96.43 | 6×IPH; 2×ZN; 2×CL; | |||
| An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological si… | homo-6-mer | 100.0 | ||||
| LVEALYL peptide derived from human insulin chain B, residues 11-17 | homo-4-mer | 100 | ||||
| Crystal structure of human insulin desB30 precursor with an Alanine-Methionine-Lysine C-peptide in … | homo-2-mer | 100 | ||||
| Crystal structure of human insulin desB30 precursor with an Aspartate-Glycine-Lysine C-peptide in d… | homo-2-mer | 100 | ||||
| Crystal structure of human insulin desB30 precursor with an Alanine-Alanine-Lysine C-peptide in dim… | homo-2-mer | 100 | ||||
| Crystal structure of the monomeric zinc free human insulin A22K, B3E, B26E, B29R, desB30 precursor … | monomer | 89.66 | ||||
| AN ACTIVE MINI-PROINSULIN, M2PI | monomer | 89.19 | ||||
| NMR Structure of Proinsulin | monomer | 96.51 | ||||
| Design of an Active Ultra-Stable Single-Chain Insulin Analog 20 Structures | monomer | 90.0 | ||||
| Solution Structure and Dynamics of an Ultra-Stable Single-Chain Insulin Analog STUDIES OF AN ENGINE… | monomer | 93.33 | ||||
| MINI-PROINSULIN, SINGLE CHAIN INSULIN ANALOG MUTANT: DES B30, HIS(B 10)ASP, PRO(B 28)ASP AND PEPTID… | monomer | 93.1 | ||||
| NMR Structures of Single-chain Insulin | monomer | 90.0 | ||||
| Solution Structure of a Heat-Resistant Long-Acting Insulin Analog | monomer | 93.55 | ||||
| Solution Structure of Human Proinsulin C-Peptide | monomer | 100 | ||||
| Highly biologically active insulin with additional disulfide bond | monomer | 95.24 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2lwz.1.A | monomer | 0.52 | 91.23 | |||